Copyright
©2013 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastrointest Oncol. Jul 15, 2013; 5(7): 115-126
Published online Jul 15, 2013. doi: 10.4251/wjgo.v5.i7.115
Published online Jul 15, 2013. doi: 10.4251/wjgo.v5.i7.115
Radiological diagnosis and staging of hilar cholangiocarcinoma
Carlos Valls, Sandra Ruiz, Laura Martinez, David Leiva, Department of Radiology, Bellvitge University Hospital, Barcelona 08907, Spain
Author contributions: All the authors contributed to the conception, design and interpretation of data and participated in drafting the manuscript, revised it critically and approved the final version; the detailed writing process and analysis of the data was performed by Valls C.
Correspondence to: Dr. Carlos Valls, Department of Radiology, Bellvitge University Hospital, Feixa Llarga s/n L'Hospitalet de Llobregat, Barcelona 08907, Spain. carlosvalls@bellvitgehospital.cat
Telephone: +34-93-3357011 Fax: +34-93-3359011
Received: January 8, 2013
Revised: June 5, 2013
Accepted: June 18, 2013
Published online: July 15, 2013
Processing time: 203 Days and 14.3 Hours
Revised: June 5, 2013
Accepted: June 18, 2013
Published online: July 15, 2013
Processing time: 203 Days and 14.3 Hours
Core Tip
Core tip: Hilar cholangiocarcinoma is a rare malignant tumor arising from the epithelium of the bile ducts. Surgery is still the only chance of potentially curative treatment in patients with perihilar cholangiocarcinoma. Multidetector computed tomography, magnetic resonance imaging and magnetic resonance cholangiography are useful tools, both to diagnose and stage hilar cholangiocarcinoma.